Q: Hi Pat: I would value your opinion on Glaukos Corporation, which makes an effective treatment for glaucoma. I have had one eye successfully treated and am waiting to have the other one done. There are hundreds of thousands of victims of this disease in the world, and no other treatment is as effective. Please comment. Kind regards.

A: Glaukos Corporation, $41.61, symbol GKOS on NYSE (Shares outstanding: 34.9 million; Market cap: $1.4 billion; www.glaukos.com), develops and markets medical devices and therapies to treat glaucoma. That disease is the result of excessive pressure on the eye’s optic nerve; it’s also the leading cause… Read More

Pengrowth loses a listing

PENGROWTH ENERGY $0.97 (Toronto symbol PGF; Shares outstanding: 547.4 million; Market cap: $539.4 million; TSINetwork Rating: Speculative; No dividends paid; www.pengrowth.com) produces oil and natural gas, mostly in Western Canada. This includes its Lindbergh oil sands project in the Cold Lake area of Alberta.
In addition to their… Read More

These funds aim for an ethical profit

The ETF world is diverse, with a fund for every kind of investment strategy. That includes ETFs for those Canadians who want to invest in companies committed to protecting the environment and helping social causes. Here are two such funds:

ISHARES MSCI KLD 400 SOCIAL… Read More

These minerals will power tomorrow’s cars

Automakers increasingly rely on lithium and rare-earth elements to make batteries for their electric vehicles (EVs). In 2017, share prices for producers of those minerals jumped on speculation EV sales will eventually lead to shortages (see Supplement, page 10).

Longer term, lithium and rare earth… Read More